What adverse effects or toxicities might occur in a 38‑year‑old patient taking methotrexate 10 mg weekly who starts a 10‑day course of amoxicillin 500 mg twice daily for streptococcal infection?

Risk of Methotrexate-Amoxicillin Interaction

The primary concern is increased methotrexate toxicity, particularly bone marrow suppression and mucositis, though at this low weekly dose (10 mg) the risk is substantially lower than with high-dose methotrexate regimens. The patient should be monitored closely but does not necessarily need to stop either medication for this short antibiotic course.

Mechanism of Interaction

Amoxicillin (a penicillin) can increase methotrexate serum levels through two mechanisms 1:

• Displacement from serum albumin binding, increasing free methotrexate
• Reduced renal tubular secretion, decreasing methotrexate clearance

The British Association of Dermatologists guidelines explicitly note that penicillins have been shown to increase methotrexate levels, though this interaction is primarily documented with high-dose methotrexate rather than the low weekly doses used for inflammatory conditions 1.

Clinical Manifestations to Monitor

If toxicity develops, watch for 2:

Early warning signs (days 1-7):

• Oral ulcers/mucositis (most common early sign)
• Nausea, vomiting, diarrhea
• Fever or flu-like symptoms
• Unusual fatigue

Hematologic toxicity (typically days 5-14):

• Pancytopenia (anemia, leukopenia, thrombocytopenia)
• Unexplained bruising or bleeding
• Increased infection susceptibility

Other organ systems:

• Hepatotoxicity (elevated transaminases)
• Renal dysfunction
• Skin reactions (rash, ulceration)

Risk Stratification for This Patient

Lower risk factors:

• Young age (38 years)
• Low methotrexate dose (10 mg weekly)
• Short antibiotic course (10 days)
• Presumably normal renal function

The interaction is most clinically significant in:

• Elderly patients
• Those with renal impairment
• High-dose methotrexate regimens (>1 g/m²)
• Prolonged antibiotic courses 3

Management Approach

During the 10-day amoxicillin course:

1. Continue both medications - The guideline states that for short antibiotic courses treating acute infections, more frequent monitoring is reasonable, but stopping methotrexate is reserved for severe infections not responding to standard treatment 1

2. Increase monitoring frequency:

   • Obtain CBC, liver enzymes, and creatinine at baseline (before or early in antibiotic course)
   • Repeat CBC at day 7-10 of antibiotic therapy
   • Repeat labs 1 week after completing antibiotics

3. Patient education - instruct to seek immediate care if:

   • Mouth sores develop
   • Fever >100.4°F
   • Unusual bruising or bleeding
   • Severe fatigue or weakness
   • Persistent nausea/vomiting

4. Ensure adequate folic acid supplementation (should already be prescribed with methotrexate) 1

When to Stop Methotrexate

The guideline recommends stopping methotrexate only if 1:

• The infection is severe
• The infection is not responding to standard antibiotic treatment
• Signs of methotrexate toxicity develop

For routine streptococcal pharyngitis responding appropriately to amoxicillin, continuation is reasonable with enhanced monitoring.

Important Caveats

The documented case of severe toxicity involved high-dose methotrexate (8 g/m²) - approximately 800-1000 times higher than this patient's weekly dose 3. The clinical significance at low weekly doses remains uncertain, as most evidence comes from high-dose oncology regimens.

The guidelines acknowledge that penicillins "have been shown to increase MTX levels when high-dose MTX is used, but this does not appear to be an issue in clinical practice" for low-dose regimens 1. However, prudent monitoring is still warranted given the potential consequences of toxicity.

If any signs of toxicity develop, immediately stop methotrexate and consider leucovorin rescue therapy (typically 15 mg IV/PO every 6 hours until symptoms resolve) 2.